An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Matthew Dallek: “Defenseless Under The Night”

Tuesday, Jul 26 2016Historian Matthew Dallek looks at the history behind the Office of Civilian Defense, the country's first agency for homeland security, and the competing visions of those tasked with spearheading the department: New York City Mayor Fiorello La Guardia and First Lady Eleanor Roosevelt.

Update On The Democratic National Convention

Tuesday, Jul 26 2016Opening night at the Democratic convention in Philadelphia. How speakers including Sen. Bernie Sanders, Sen. Elizabeth Warren and First Lady Michelle Obama seek to bridge party divides and build the case for presumptive nominee Hillary Clinton.

Verdine White On 45 Years With Earth, Wind & Fire

Monday, Jul 25 2016Forty-five years ago, the band “Earth, Wind and Fire” introduced audiences to a new kind of funk--one that fused soul, jazz, Latin and pop. Bassist Verdine White talks to guest host Derek McGinty about breaking racial boundaries in music and how the band is still evolving.